Literature DB >> 19535958

Fever in the critically ill medical patient.

Kevin B Laupland1.   

Abstract

Fever, commonly defined by a temperature of >or=38.3 degrees C (101 degrees F), occurs in approximately one half of patients admitted to intensive care units. Fever may be attributed to both infectious and noninfectious causes, and its development in critically ill adult medical patients is associated with an increased risk for death. Although it is widespread and clinically accepted practice to therapeutically lower temperature in patients with hyperthermic syndromes, patients with marked hyperpyrexia, and selected populations such as those with neurologic impairment, it is controversial whether most medical patients with moderate degrees of fever should be treated with antipyretic or direct cooling therapies. Although treatment of fever may improve patient comfort and reduce metabolic demand, fever is a normal adaptive response to infection and its suppression is potentially harmful. Clinical trials specifically comparing fever management strategies in neurologically intact critically ill medical patients are needed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19535958     DOI: 10.1097/CCM.0b013e3181aa6117

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  26 in total

1.  Evaluation of stat orders in a teaching hospital: a chart review.

Authors:  Fanak Fahimi; Zahra Sahraee; Shahideh Amini
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

2.  Treatment of resistant fever: new method of local cerebral cooling.

Authors:  Susanne Mink; Urs Schwarz; Regina Mudra; Christoph Gugl; Jürg Fröhlich; Emanuela Keller
Journal:  Neurocrit Care       Date:  2011-08       Impact factor: 3.210

3.  Clinical management of fever by nurses: doing what works.

Authors:  Hilaire J Thompson; Sarah H Kagan
Journal:  J Adv Nurs       Date:  2010-11-02       Impact factor: 3.187

4.  The occurrence of pneumonia diagnosis among neurosurgical patients: the definition matters.

Authors:  Petri Kuusinen; Tero Ala-Kokko; Airi Jartti; Lauri Ahvenjarvi; Pirjo Saynajakangas; Pasi Ohtonen; Hannu Syrjala
Journal:  Neurocrit Care       Date:  2012-02       Impact factor: 3.210

5.  Management of severe infections: A time to keep a cool head or a hot topic for clinical trials?

Authors:  Kevin B Laupland; Louis Valiquette
Journal:  Can J Infect Dis Med Microbiol       Date:  2014       Impact factor: 2.471

6.  The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016).

Authors:  Osamu Nishida; Hiroshi Ogura; Moritoki Egi; Seitaro Fujishima; Yoshiro Hayashi; Toshiaki Iba; Hitoshi Imaizumi; Shigeaki Inoue; Yasuyuki Kakihana; Joji Kotani; Shigeki Kushimoto; Yoshiki Masuda; Naoyuki Matsuda; Asako Matsushima; Taka-Aki Nakada; Satoshi Nakagawa; Shin Nunomiya; Tomohito Sadahiro; Nobuaki Shime; Tomoaki Yatabe; Yoshitaka Hara; Kei Hayashida; Yutaka Kondo; Yuka Sumi; Hideto Yasuda; Kazuyoshi Aoyama; Takeo Azuhata; Kent Doi; Matsuyuki Doi; Naoyuki Fujimura; Ryota Fuke; Tatsuma Fukuda; Koji Goto; Ryuichi Hasegawa; Satoru Hashimoto; Junji Hatakeyama; Mineji Hayakawa; Toru Hifumi; Naoki Higashibeppu; Katsuki Hirai; Tomoya Hirose; Kentaro Ide; Yasuo Kaizuka; Tomomichi Kan'o; Tatsuya Kawasaki; Hiromitsu Kuroda; Akihisa Matsuda; Shotaro Matsumoto; Masaharu Nagae; Mutsuo Onodera; Tetsu Ohnuma; Kiyohiro Oshima; Nobuyuki Saito; So Sakamoto; Masaaki Sakuraya; Mikio Sasano; Norio Sato; Atsushi Sawamura; Kentaro Shimizu; Kunihiro Shirai; Tetsuhiro Takei; Muneyuki Takeuchi; Kohei Takimoto; Takumi Taniguchi; Hiroomi Tatsumi; Ryosuke Tsuruta; Naoya Yama; Kazuma Yamakawa; Chizuru Yamashita; Kazuto Yamashita; Takeshi Yoshida; Hiroshi Tanaka; Shigeto Oda
Journal:  Acute Med Surg       Date:  2018-02-05

7.  Hyperpyrexia as the Presenting Symptom of Intracranial Hypotension.

Authors:  Omar Hussein; Michel Torbey
Journal:  Neurocrit Care       Date:  2018-06       Impact factor: 3.210

8.  Admission Body Temperature in Critically Ill Patients as an Independent Risk Predictor for Overall Outcome.

Authors:  Ralf Erkens; Bernhard Wernly; Maryna Masyuk; Johanna M Muessig; Marcus Franz; Paul Christian Schulze; Michael Lichtenauer; Malte Kelm; Christian Jung
Journal:  Med Princ Pract       Date:  2019-12-02       Impact factor: 1.927

9.  The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016).

Authors:  Osamu Nishida; Hiroshi Ogura; Moritoki Egi; Seitaro Fujishima; Yoshiro Hayashi; Toshiaki Iba; Hitoshi Imaizumi; Shigeaki Inoue; Yasuyuki Kakihana; Joji Kotani; Shigeki Kushimoto; Yoshiki Masuda; Naoyuki Matsuda; Asako Matsushima; Taka-Aki Nakada; Satoshi Nakagawa; Shin Nunomiya; Tomohito Sadahiro; Nobuaki Shime; Tomoaki Yatabe; Yoshitaka Hara; Kei Hayashida; Yutaka Kondo; Yuka Sumi; Hideto Yasuda; Kazuyoshi Aoyama; Takeo Azuhata; Kent Doi; Matsuyuki Doi; Naoyuki Fujimura; Ryota Fuke; Tatsuma Fukuda; Koji Goto; Ryuichi Hasegawa; Satoru Hashimoto; Junji Hatakeyama; Mineji Hayakawa; Toru Hifumi; Naoki Higashibeppu; Katsuki Hirai; Tomoya Hirose; Kentaro Ide; Yasuo Kaizuka; Tomomichi Kan'o; Tatsuya Kawasaki; Hiromitsu Kuroda; Akihisa Matsuda; Shotaro Matsumoto; Masaharu Nagae; Mutsuo Onodera; Tetsu Ohnuma; Kiyohiro Oshima; Nobuyuki Saito; So Sakamoto; Masaaki Sakuraya; Mikio Sasano; Norio Sato; Atsushi Sawamura; Kentaro Shimizu; Kunihiro Shirai; Tetsuhiro Takei; Muneyuki Takeuchi; Kohei Takimoto; Takumi Taniguchi; Hiroomi Tatsumi; Ryosuke Tsuruta; Naoya Yama; Kazuma Yamakawa; Chizuru Yamashita; Kazuto Yamashita; Takeshi Yoshida; Hiroshi Tanaka; Shigeto Oda
Journal:  J Intensive Care       Date:  2018-02-02

10.  Diagnostic Accuracy of Various Biomarkers of Sepsis (Serum Pro-Calcitonin, High-Sensitivity C-reactive Protein, and C-reactive Protein) and Band Cell Percentage in Critically lll Patients: A Prospective, Observational, Cohort Study.

Authors:  Bikram Kumar Gupta; Badri Prasad Das; Vanita Ramesh Mhaske; Shubham Tomar; Kapil Rastogi
Journal:  Anesth Essays Res       Date:  2021-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.